11 suspended. 11 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Suspended 11 |
| Phase 2 | 4 | Suspended 4 |
Follow Pneumonia: new trials by email Literature Review of Pneumonia trials Research Report on Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 RESP301 - Pulmonary Complications in Surgical Patients, COVID | Phase 3 | Suspended | University of Birmingham | 6400 | 2022-05-16 | 2025-02-20 |
| Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 Yinhu Qingwen Granula, Yin Hu Qing Wen Granula(low does), standard medical treatment - COVID-19, Severe Pneumonia | Phase 2 / Phase 3 | Suspended | Zhong Wang | 116 | 2021-11-01 | 2021-07-07 |
| Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation Leronlimab, Placebo - COVID-19 Pneumonia | Phase 3 | Suspended | Hospital Israelita Albert Einstein | 316 | 2021-10-23 | 2022-04-15 |
| Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19 YinHu QingWen Decoction, YinHu QingWen Decoction(low dose), Chinese medicine treatment - CoVID-19, Chinese Medicine | Phase 2 / Phase 3 | Suspended | China Academy of Chinese Medical Sciences | 300 | 2021-10-01 | 2021-07-07 |
| Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia Leronlimab, Placebo - COVID-19 Pneumonia | Phase 3 | Suspended | Hospital Israelita Albert Einstein | 612 | 2021-09-09 | 2022-04-15 |
| CBD Oil for Reducing Emotional Impact of COVID-19 CBD Isolate, Full Spectrum CBD Oil, Broad-Spectrum CBD Oil - Anxiety Depression, Alcohol Abuse | Phase 2 / Phase 3 | Suspended | University of Texas at Austin | 200 | 2020-12-04 | 2023-11-22 |
| Measles Vaccine in HCW Measles-Mumps-Rubella Vaccine, Placebos - Covid19 | Phase 3 | Suspended | Kasr El Aini Hospital | 200 | 2020-07-13 | 2020-12-22 |
| VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL) Hydroxychloroquine, Azithromycin, Placebo oral tablet - SARS-CoV-2, COVID-19 | Phase 3 | Suspended | Salomeh Keyhani MD | 300 | 2020-04-30 | 2020-06-22 |
| Proactive Care of Ambulatory COVID19 Patients consultation, Azithromycin - Covid19, Azithromycin | Phase 3 | Suspended | Centre Hospitalier Universitaire, Amiens | 11 | 2020-04-29 | 2023-03-21 |
| Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO Sarilumab, Azithromycin, Hydroxychloroquine - COVID19, SARS-CoV-2 Infection | Phase 2 / Phase 3 | Suspended | Assistance Publique - Hôpitaux de Paris | 27 | 2020-04-11 | 2020-05-06 |
| A Trial of Remdesivir in Adults With Mild and Moderate COVID-19 Remdesivir, Remdesivir placebo - COVID-19, SARS-CoV-2 | Phase 3 | Suspended | Capital Medical University | 308 | 2020-02-12 | 2020-04-15 |
COVID-19 (11) · Alcoholism (1) · Fractures, Stress (1) · Parasomnias (1) · Respiratory Insufficiency (1) · Severe Acute Respiratory Syndrome (1) · Substance-Related Disorders (1)
Coronaviridae Infections (11) · Coronavirus Infections (11) · Infections (11) · Lung Diseases (11) · Nidovirales Infections (11) · Pneumonia, Viral (11) · RNA Virus Infections (11) · Respiratory Tract Diseases (11) · Respiratory Tract Infections (11) · Virus Diseases (11) · Alcohol-Related Disorders (1) · Chemically-Induced Disorders (1) · Fractures, Bone (1) · Mental Disorders (1)
Azithromycin (3) · Hydroxychloroquine (2) · leronlimab (2) · Measles-Mumps-Rubella Vaccine (1) · Referral and Consultation (1) · remdesivir (1) · sarilumab (1)
Hospital Israelita Albert Einstein (2) · Assistance Publique - Hôpitaux de Paris (1) · Capital Medical University (1) · Centre Hospitalier Universitaire, Amiens (1) · China Academy of Chinese Medical Sciences (1) · Kasr El Aini Hospital (1) · Salomeh Keyhani MD (1) · University of Birmingham (1) · University of Texas at Austin (1) · Zhong Wang (1)
China (3) · Brazil (2) · France (2) · United States (2) · Egypt (1) · Nigeria (1) · Rwanda (1)
Jiang-Rong Huang, M.D. (2) · Xiao-Dong Li, M.D. (2) · Aneel Bhangu (1) · Dong Shang, M.D. (1) · Jean-Philippe Lanoix, Pr (1) · Michael J Telch, Ph.D. (1) · Salomeh Keyhani, MD MPH (1) · Wei Zhang (1) · Zhong Wang, M.D. (1)